June 9, 2020: Safety Bulletin - New! Buprenorphine/Naloxone and Methadone Handouts for Patients: Your Questions Answered
Key stakeholders in Saskatchewan identified an information need among patients who are initiating opioid agonist therapy for treatment of opioid use disorder. In response, several provincial and national organizations collaborated to develop handouts for patients for whom buprenorphine/naloxone or methadone has been prescribed. These handouts share advice about the risks, benefits, and adverse effects of buprenorphine/ naloxone and methadone, as well as tips on proper storage and disposal of these drugs. Read more ...
